Israeli co Nasus Pharma completes Wall Road IPO
The Tel Aviv-based firm develops powder-based Intranasal specialised therapies. Israeli firm Nasus Pharma (NYSE: NSRX), which develops ...
The Tel Aviv-based firm develops powder-based Intranasal specialised therapies. Israeli firm Nasus Pharma (NYSE: NSRX), which develops ...